-
Alzheimer’s drug Leqembi moves forward, still in low gear
24 Apr 2024 19:21 GMT
… on the rollout of its Eisai-partnered Alzheimer’s disease therapy … results, showing that while the drug’s take-up is building … treatment with the anti-amyloid drug.
Biogen also pointed to an … about its benefits among physicians.
Eisai, which is taking the lead …
-
Biogen to invest more in launch of Alzheimer’s drug Leqembi
24 Apr 2024 19:18 GMT
… have been worked through.
The drug, branded as Leqembi, generated $ …
The growing demand has convinced Eisai and Biogen the time has … for Leqembi, getting the drug to patients has proven more … access to Leqembi.
Administering the drug is another challenge, as …
-
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
24 Apr 2024 18:55 GMT
… Approval Decision For Biogen-Eisai Partnered Alzheimer’s Drug Lecanemab.
Reuters highlighted … fatalistic attitudes toward cancer treatment. Eisai’s chief administrative officer, Alex … long adoption cycles for new drugs and concerns about Leqembi’s …
-
Biogen stock climbs on strong Alzheimer’s drug sales
24 Apr 2024 15:54 GMT
… Japanese business partner, Eisai. It is the first drug that experts agree … of Leqembi, which Biogen and Eisai hope will ultimately be a …
Biogen is focusing on newer drugs to spur growth for the … years, as its multiple sclerosis drugs — long the mainstay of the …
-
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
24 Apr 2024 13:39 GMT
… drug, Leqembi, came in higher than expected.
Biogen and Eisai… #39;s Leqembi became the first drug found to … eyes on other newly launched drugs.
That includes Skyclarys, … sales of that drug, FactSet said.
Multiple sclerosis drugs, other treatments …
-
Eisai and BioArctic sign research evaluation agreement for potential new Alzheimer’s treatment
24 Apr 2024 11:37 GMT
… the development and commercialisation of drugs for the treatment of … AD drug candidate.
At the end of the collaboration, Eisai will … .”
Since 2005, BioArctic and Eisai’s collaboration has led to … approved drug to slow the progression of early AD.
While Eisai …
-
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
24 Apr 2024 11:27 GMT
… cost-cutting measures as older drugs face fierce competition. The company … Alzheimer's drug Leqembi, developed with Japanese partner Eisai, recorded global … 's drug Leqembi, as its multiple sclerosis drugs and its spinal …
-
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
23 Apr 2024 19:04 GMT
… ' reproductive health data.
Alzheimer Drug Faces Adoption Hurdles
Nine months … -irmb (Leqembi; Eisai and Biogen), the pioneering Alzheimer drug continues to face …
-
First drug that slows down Alzheimer’s disease already exists, but why doctors are skeptical?
23 Apr 2024 18:35 GMT
… the U.S. Food and Drug Administration, as evidenced by … Leqembi, citing doubts about the drug’s effectiveness, its cost, … of January, as reported by Eisai, whose spokeswoman declined to … figures.
The adoption of new drugs, even those not requiring significant …
-
UK Pharmacy dean continuing work with promising anti-malarial drug
23 Apr 2024 12:11 GMT
… ’s Research Hospital in Tennessee, Eisai in both the United States … in the anti-malarial drug project between Eisai Co., Ltd. and the … to be made for these drugs. “There is not just a … so to speak. All the drugs that have gone forward have …